(Q45706430)

English

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

scientific article published in December 2003

Statements

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (English)
American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit